Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Clinical trial NCT06235775 · COMPLETED

Trial details

NCT number: NCT06235775
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy

Start date: 2023-12-12
Primary completion: 2025-09-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.